Long PA, Zimmermann MT, Kim M, Evans JM, Xu X, Olson TM

De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.

Hum Genet 135:909-917 (2016)
DOI:10.1007/s00439-016-1685-3

Reijnders MRF, Seibt A, Brugger M, Lamers IJC, Ott T, Klaas O, Horvath J, Rose AMS, Craghill IM, Brunet T, Graf E, Mayerhanser K, Hellebrekers D, Pauck D, Neuen-Jacob E, Rodenburg RJT, Wieczorek D, Klee D, Mayatepek E, Driessen G, Bindermann R, Averdunk L, Lohmeier K, Sinnema M, Stegmann APA, Roepman R, Poulter JA, Distelmaier F

De novo missense variants in RRAGC lead to a fatal mTORopathy of early childhood.

Genet Med 25:100838 (2023)
DOI:10.1016/j.gim.2023.100838